CTAG1B / NY-ESO-1 Antibody (clone OTI3F10)
Catalog Number: LS-C114597-100
100 µL (0.95 mg/mL) / $443.00
Antibody: Mouse Monoclonal
Applications: Immunofluorescence, Western Blot
Reactivity: Human
Format: Liquid
Human CTAG1B / NY-ESO-1 Protein (Recombinant 6His, N-terminus)
ProteinLSBio Guarantee
| Expression System | Other |
| Format: | Lyophilized |
$343.00each
Catalog Number: LS-G22876-20
Catalog Number: LS-G22876
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- CTAG1A and CTAG1B have identical sequences. They are the result of a duplicated region of the X-chromosome.
- Category
- Proteins & Peptides > Proteins > Recombinant Proteins
- Alternative Names
- Cancer/testis antigen 1B | CTAG1B | Cancer antigen 3 | Cancer/testis antigen 1 | Cancer/testis antigen 6.1 | CTAG | CT6.1 | LAGE2A | L antigen family member 2 | LAGE-2 | LAGE2 | NY-ESO-1 | CTAG1 | ESO1 | LAGE2B | CTAG1A
- Origin Species
- Human
- NCBI GenBank
- NM_001327|NP_001318.1
- SwissProt
- P78358
Protein
- Expression System
- Other
- Fusion Tag
- Hexahistidine Tag
- Molecular Weight
- 20 kD
- Protein Type
- Recombinant
- Amino Acid Sequence
1aa 1-180|M QAEGRGTGGS TGDADGPGGP GIPDGPGGNA GGPGEAGATG GRGPRGAGAA61RASGPGGGAP RGPHGGAASG LNGCCRCGAR GPESRLLEFY LAMPFATPME AELARRSLAQ121DAPPLPVPGV LLKEFTVSGN ILTIRLTAAD HRQLQLSISS CLQQLSLLMW ITQCFLPVFL181AQPPSGQRR
189 aa
Format
- Conjugate/Label
- Unconjugated
- Endotoxin Level
- Not Tested
- Format
- Lyophilized
- Formulation
- Lyophilized from 20mM Tris-HCl, pH 8.0, 0.5M NaCl, 6% Trehalose
- Concentration
- 0.5 mg/mL
Storage & Handling
- Storage Conditions
- Short term: store at 4°C for up to 1 week. Long term: store at -20°C to -80°C. Avoid freeze-thaw cycles.
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. Fässler M, Diem S, Mangana J, Hasan Ali O, Berner F, Bomze D, Ring S, Niederer R, Del Carmen Gil Cruz C, Pérez Shibayama CI, Krolik M, Siano M, Joerger M, Recher M, Risch L, Güsewell S, Risch M, Speiser DE, Ludewig B, Levesque MP, Dummer R, Flatz L. Journal for immunotherapy of cancer. 2019 February;7:50. PubMed: 30786924 PMC: PMC6383238
